4.11

0.72% -0.03

After Hours: 4.15 0.04 +0.97%

Mereo Biopharma Group Plc Adr (MREO)

Overview News Price History Option Chain Discussions Forecast

Mereo Biopharma Group Plc Adr stock is traded at $4.11, with a volume of 592.51K. It is down -0.72% in the last 24 hours and down -12.37% over the past month. Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Previous Close:

$4.14

Open:

$4.16

24h Volume:

592.51K

Relative Volume:

0.67

Market Cap:

$636.95M

Revenue:

$10.00M

Net Income/Loss:

$-29.47M

P/E Ratio:

-13.63

EPS:

-0.3015

Net Cash Flow:

$-21.55M

1W Performance:

+0.49%

1M Performance:

-12.37%

6M Performance:

+24.55%

1Y Performance:

+218.60%

1-Day Range:

$4.00

$4.1993

1-Week Range:

$3.95

$4.22

52-Week Range:

$1.07

$5.02

Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile

Name

Mereo Biopharma Group Plc Adr

Sector

Healthcare (1190)

Industry

Biotechnology (681)

Phone

4403330237300

Address

ONE CAVENDISH PLACE, LONDON

Employee

Twitter

@MereoBioPharma

Next Earnings Date

2024-09-05

Latest SEC Filings

MREO's Discussions on Twitter

Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-13-23	Resumed	BTIG Research	Buy
Aug-12-22	Initiated	Cantor Fitzgerald	Overweight
May-05-21	Initiated	BTIG Research	Buy
Apr-05-21	Initiated	Needham	Buy

Mereo Biopharma Group Plc Adr Stock (MREO) Latest News

02:09 AM

Market Recap Check: Mereo Biopharma Group Plc ADR (MREO)’s Positive Finish at 4.14, Up/Down 0.98 - The Dwinnex

02:09 AM

Sep 27, 2024

Mereo Biopharma Group Plc ADR [NASDAQ: MREO] Sees Increase in Stock Value - Knox Daily

Sep 27, 2024

A Look at Mereo Biopharma Group Plc ADR (MREO) Shares in the Recent Past Indicates Growth - SETE News

Sep 27, 2024

Sep 25, 2024

Examining Mereo Biopharma Group Plc ADR (MREO) more closely is necessary - US Post News

Sep 25, 2024

Sep 24, 2024

Xylem Inc [XYL] stock was sold by Harker Victoria D at the price of US$0.35 million - Knox Daily

Sep 24, 2024

Chief Executive Officer, Scots-Knight Denise sold 60,046 shares of Mereo Biopharma Group Plc ADR [MREO] - Knox Daily

Sep 24, 2024

Verona Pharma Plc ADR [VRNA] President and CEO makes an insider sale of 600,000 shares worth $2.25 million. - Knox Daily

Sep 24, 2024

MULN’s latest rating updates from top analysts. - Knox Daily

Sep 24, 2024

Truist analysts initates a Hold rating for Expedia Group Inc (EXPE) - Knox Daily

Sep 24, 2024

Closing Strong: Mereo Biopharma Group Plc ADR (MREO) Ends at 4.09, Down -3.76 from Last Close - The Dwinnex

Sep 24, 2024

Sep 20, 2024

OKX Ventures and Aptos Foundation Announce First Four Projects Selected for the Ankaa Accelerator Program - GlobeNewswire Inc.

Sep 20, 2024

Sep 19, 2024

Canopy Growth Corporation [CGC] Shares Fall -2.45 % on Wednesday - Knox Daily

Sep 19, 2024

Sep 18, 2024